Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
2301
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $12.5M | ﹤0.01% |
830,337
+75,651
| +10% | +$1.14M |
|
2302
Atossa Therapeutics
ATOS
$22.8M
| $12.4M | ﹤0.01% |
131,250
+98,709
| +303% | +$5.23M |
|
2303
QCR Holdings
QCRH
$1.71B
| $12.4M | ﹤0.01% |
258,734
+2,680
| +1% | +$128K |
|
2304
A10 Networks
ATEN
$2.28B
| $12.4M | ﹤0.01% |
1,104,131
+68,970
| +7% | +$668K |
|
|
VIEW
2305
DELISTED
View, Inc. Class A Common Stock
VIEW
| $12.4M | ﹤0.01% |
24,346
+22,190
| +1,029% | +$10.9M |
|
2306
OraSure Technologies
OSUR
$283M
| $12.4M | ﹤0.01% |
1,221,247
+47,486
| +4% | +$462K |
|
|
UBA
2307
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $12.4M | ﹤0.01% |
638,538
+11,074
| +2% | +$205K |
|
|
TDAY
2308
USA Today Co
TDAY
$1.33B
| $12.4M | ﹤0.01% |
2,251,054
+112,458
| +5% | +$574K |
|
2309
Hayward Holdings
HAYW
$3.33B
| $12.3M | ﹤0.01% |
+474,275
| New | +$10.4M |
|
2310
Karyopharm Therapeutics
KPTI
$45.8M
| $12.3M | ﹤0.01% |
79,685
+3,237
| +4% | +$470K |
|
|
VLDR
2311
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $12.3M | ﹤0.01% |
1,156,593
+638,878
| +123% | +$7.54M |
|
2312
Gorman-Rupp
GRC
$2.23B
| $12.3M | ﹤0.01% |
357,147
+39,304
| +12% | +$1.37M |
|
2313
Seaboard Corp
SEB
$4.25B
| $12.3M | ﹤0.01% |
3,178
+234
| +8% | +$877K |
|
|
CTT
2314
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $12.3M | ﹤0.01% |
1,050,579
+24,882
| +2% | +$289K |
|
2315
Great Southern Bancorp
GSBC
$876M
| $12.3M | ﹤0.01% |
227,791
-2,595
| -1% | -$146K |
|
|
BFS
2316
Saul Centers
BFS
$834M
| $12.3M | ﹤0.01% |
269,835
+23,755
| +10% | +$1.03M |
|
|
VBIV
2317
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $12.3M | ﹤0.01% |
121,906
+5,895
| +5% | +$575K |
|
|
CNSL
2318
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $12.2M | ﹤0.01% |
1,391,959
+24,742
| +2% | +$199K |
|
2319
C3.ai
AI
$1.51B
| $12.2M | ﹤0.01% |
195,402
+20,361
| +12% | +$1.27M |
|
|
ATRS
2320
DELISTED
Antares Pharma, Inc.
ATRS
| $12.2M | ﹤0.01% |
2,799,516
+144,725
| +5% | +$590K |
|
2321
Aspen Aerogels
ASPN
$408M
| $12.2M | ﹤0.01% |
406,689
+24,234
| +6% | +$495K |
|
2322
Par Pacific Holdings
PARR
$4.12B
| $12.2M | ﹤0.01% |
722,506
+81,916
| +13% | +$1.23M |
|
2323
Syndax Pharmaceuticals
SNDX
$1.72B
| $12.1M | ﹤0.01% |
706,942
+140,019
| +25% | +$2.56M |
|
|
AERI
2324
DELISTED
Aerie Pharmaceuticals
AERI
| $12.1M | ﹤0.01% |
756,214
+58,927
| +8% | +$1.01M |
|
|
LAND
2325
Gladstone Land Corp
LAND
$342M
| $12.1M | ﹤0.01% |
502,552
+69,561
| +16% | +$1.57M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.